MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice

References

• Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):343–359. doi:10.1080/17476348.2017.1312346
   PubMed Web of Science ®Google Scholar
• Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952. doi:10.1016/S0140-6736(17)30866-8
   PubMed Web of Science ®Google Scholar
• Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–968. doi:10.1056/NEJMra2005230
   PubMed Web of Science ®Google Scholar
• Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518–1531. doi:10.1007/s12325-019-00992-9
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–215. doi:10.1016/j.smim.2015.03.004
   PubMed Web of Science ®Google Scholar
• Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51–67. doi:10.1038/nri.2015.4
   PubMed Web of Science ®Google Scholar
• Dalli J, Vlasakov I, Riley IR, et al. Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages. Proc Natl Acad Sci U S A. 2016;113(43):12232–12237. doi:10.1073/pnas.1607003113
   PubMed Web of Science ®Google Scholar
• Li H, Hao Y, Yang LL, et al. MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx. J Cell Physiol. 2020;235(10):7283–7294. doi:10.1002/jcp.29628
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhu Y, Xiao J, et al. Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function. Biochem Pharmacol. 2020;177:114005. doi:10.1016/j.bcp.2020.114005
   PubMed Web of Science ®Google Scholar
• Han J, Li H, Bhandari S, et al. Maresin conjugates in tissue regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, K-ATPase in lipopolysaccharide-induced acute lung injury. J Cell Mol Med. 2020;24(8):4736–4747. doi:10.1111/jcmm.15146
   PubMed Web of Science ®Google Scholar
• Li H, Hao Y, Zhang H, et al. Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice. Sci Rep. 2017;7:46754. doi:10.1038/srep46754
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Zhou Y, Gaggar A, et al. Fibrosis: ultimate and proximate causes. J Clin Invest. 2014;124(11):4673–4677. doi:10.1172/JCI74368
   PubMed Web of Science ®Google Scholar
• George PM, Spagnolo P, Kreuter M, et al. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med. 2020;8(9):925–934. doi:10.1016/S2213-2600(20)30355-6
   PubMed Web of Science ®Google Scholar
• Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol. 2011;73:413–435. doi:10.1146/annurev-physiol-012110-142225
   PubMed Web of Science ®Google Scholar
• Rangarajan S, Bone NB, Zmijewska AA, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121–1127. doi:10.1038/s41591-018-0087-6
   PubMed Web of Science ®Google Scholar
• Yu G, Tzouvelekis A, Wang R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24(1):39–49. doi:10.1038/nm.4447
   PubMed Web of Science ®Google Scholar
• Kheirollahi V, Wasnick RM, Biasin V, et al. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis. Nat Commun. 2019;10(1):2987. doi:10.1038/s41467-019-10839-0
   PubMed Web of Science ®Google Scholar
• LaRocca G, Aspelund T, Greve AM, et al. Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study. Eur Heart J. 2017;38(46):3423–3430. doi:10.1093/eurheartj/ehx510
   PubMed Web of Science ®Google Scholar
• Oh K, Park HB, Byoun OJ, et al. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med. 2011;208(8):1707–1719. doi:10.1084/jem.20101457
   PubMed Web of Science ®Google Scholar
• Kolb M, Margetts PJ, Anthony DC, et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107(12):1529–1536. doi:10.1172/JCI12568
   PubMed Web of Science ®Google Scholar
• Su J, Morgani SM, David CJ, et al. TGF-beta orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. 2020;577(7791):566–571. doi:10.1038/s41586-019-1897-5
   PubMed Web of Science ®Google Scholar
• Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21(9):998–1009. doi:10.1038/nm.3902
   PubMed Web of Science ®Google Scholar
• Vanoirbeek JA, Rinaldi M, De Vooght V, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol. 2010;42(1):96–104. doi:10.1165/rcmb.2008-0487OC
   PubMed Web of Science ®Google Scholar
• Pillow JJ, Musk GC, McLean CM, et al. Variable ventilation improves ventilation and lung compliance in preterm lambs. Intensive Care Med. 2011;37(8):1352–1359. doi:10.1007/s00134-011-2237-x
   PubMed Web of Science ®Google Scholar
• Darrah RJ, Mitchell AL, Campanaro CK, et al. Early pulmonary disease manifestations in cystic fibrosis mice. J Cyst Fibros. 2016;15(6):736–744. doi:10.1016/j.jcf.2016.05.002
   PubMed Web of Science ®Google Scholar